explore -WSS

explore

author：entertainment 2025-10-02 23:47:13 - browse：112

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Getting Alzheimer's drug Leqembi to patients can be a challenge

hotspot

WSS

Congenital heart disease patients face new threat of heart failure

Close Medicare's dangerous gaps in addiction treatment coverage

SCOTUS to consider access to abortion pill mifepristone

MultiPlan and major insurers sued for alleged medical price

More tobacco lobbyists active in statehouses

Supreme Court wrestles with OxyContin maker's bankruptcy deal

focus

explore

knowledge

Sports medicine is finally prioritizing gender equality

The woman behind the Dana Farber

Jerome Adams on the need for new antivirals for Covid

Q&A: Jennifer Adair on making gene therapy available globally

Heart attack and stroke risk calculators need revising

After sickle

Virginia high school admissions case could be legal follow

H5N1 bird flu virus started spreading in cows in Texas in December

After affirmative action ruling, medical educators look to 'holistic review'

Cell therapy fails to slow type 1 diabetes, but safety is established

Wikipedia

MassMutual is introducing free genetic testing for members

STAT letters to the editor on burnt

Key Senate committee drafts bipartisan bill to stem drug shortages

Orangutan used medicinal plant to treat wound, first time ever seen

Why rehabilitation engineers need to center patients in their research

Bird flu in milk supply is likely coming from asymptomatic cows

hotspot

entertainment

focus

explore